Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07572383Phase 2Recruiting

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Role: lead

NCT06532071Phase 2Recruiting

Advanced Imaging for Pulmonary Fibrosis

Role: lead

NCT04022915Phase 1Terminated

PET Fibrin Imaging of DVT and PE

Role: lead

All 3 trials loaded